|
1
|
Shi Y, He B, You L and Jablons DM: Roles
of secreted frizzled-related proteins in cancer. Acta Pharmacol
Sin. 28:1499–1504. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Uematsu K, He B, You L, Xu Z, McCormick F
and Jablons DM: Activation of the Wnt pathway in non small cell
lung cancer: Evidence of dishevelled overexpression. Oncogene.
22:7218–7221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clevers H and Batlle E: EphB/EphrinB
receptors and Wnt signaling in colorectal cancer. Cancer Res.
66:2–5. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weeraratna AT, Jiang Y, Hostetter G,
Rosenblatt K, Duray P, Bittner M and Trent JM: Wnt5a signaling
directly affects cell motility and invasion of metastatic melanoma.
Cancer Cell. 1:279–288. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M,
Leoni LM, Kipps TJ, Corr M and Carson DA: Activation of the Wnt
signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad
Sci USA. 101:3118–3123. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar
|
|
8
|
Veeman MT, Axelrod JD and Moon RT: A
second canon. Functions and mechanisms of beta-catenin-independent
Wnt signaling. Dev Cell. 5:367–377. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arce L, Yokoyama NN and Waterman ML:
Diversity of LEF/TCF action in development and disease. Oncogene.
25:7492–7504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Courtwright A, Siamakpour-Reihani S,
Arbiser JL, Banet N, Hilliard E, Fried L, Livasy C, Ketelsen D,
Nepal DB, Perou CM, et al: Secreted frizzle-related protein 2
stimulates angiogenesis via a calcineurin/NFAT signaling pathway.
Cancer Res. 69:4621–4628. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mirotsou M, Zhang Z, Deb A, Zhang L,
Gnecchi M, Noiseux N, Mu H, Pachori A and Dzau V: Secreted frizzled
related protein 2 (Sfrp2) is the key Akt-mesenchymal stem
cell-released paracrine factor mediating myocardial survival and
repair. Proc Natl Acad Sci USA. 104:1643–1648. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JL, Chang CJ, Wu SY, Sargan DR and Lin
CT: Secreted frizzled-related protein 2 (SFRP2) is highly expressed
in canine mammary gland tumors but not in normal mammary glands.
Breast Cancer Res Treat. 84:139–149. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gehmert S, Sadat S, Song YH, Yan Y and Alt
E: The anti-apoptotic effect of IGF-1 on tissue resident stem cells
is mediated via PI3-kinase dependent secreted frizzled related
protein 2 (Sfrp2) release. Biochem Biophys Res Commun. 371:752–755.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JL, Chang CJ, Chueh LL and Lin CT:
Secreted frizzled related protein 2 (sFRP2) decreases
susceptibility to UV-induced apoptosis in primary culture of canine
mammary gland tumors by NF-kappaB activation or JNK suppression.
Breast Cancer Res Treat. 100:49–58. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roth W, Wild-Bode C, Platten M, Grimmel C,
Melkonyan HS, Dichgans J and Weller M: Secreted Frizzled-related
proteins inhibit motility and promote growth of human malignant
glioma cells. Oncogene. 19:4210–4220. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fontenot E, Rossi E, Mumper R, Snyder S,
Siamakpour-Reihani S, Ma P, Hilliard E, Bone B, Ketelsen D, Santos
C, et al: A novel monoclonal antibody to secreted frizzled-related
protein 2 inhibits tumor growth. Mol Cancer Ther. 12:685–695. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsuruta JK, Klauber-DeMore N, Streeter J,
Samples J, Patterson C, Mumper RJ, Ketelsen D and Dayton P:
Ultrasound molecular imaging of secreted frizzled related protein-2
expression in murine angiosarcoma. PLoS One. 9:e866422014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sathi GA, Inoue M, Harada H, Rodriguez AP,
Tamamura R, Tsujigiwa H, Borkosky SS, Gunduz M and Nagatsuka H:
Secreted frizzled related protein (sFRP)-2 inhibits bone formation
and promotes cell proliferation in ameloblastoma. Oral Oncol.
45:856–860. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao C, Wang L, Zhu L, Zhang C and Zhou J:
Secreted frizzled-related protein 2 is epigenetically silenced and
functions as a tumor suppressor in oral squamous cell carcinoma.
Mol Med Rep. 10:2293–2298. 2014.PubMed/NCBI
|
|
22
|
Suzuki H, Toyota M, Carraway H, Gabrielson
E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T,
et al: Frequent epigenetic inactivation of Wnt antagonist genes in
breast cancer. Br J Cancer. 98:1147–1156. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sogabe Y, Suzuki H, Toyota M, Ogi K, Imai
T, Nojima M, Sasaki Y, Hiratsuka H and Tokino T: Epigenetic
inactivation of SFRP genes in oral squamous cell carcinoma. Int J
Oncol. 32:1253–1261. 2008.PubMed/NCBI
|
|
24
|
Takagi H, Sasaki S, Suzuki H, Toyota M,
Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K, et al:
Frequent epigenetic inactivation of SFRP genes in hepatocellular
carcinoma. J Gastroenterol. 43:378–389. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hüsemann Y, Geigl JB, Schubert F, Musiani
P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G, et
al: Systemic spread is an early step in breast cancer. Cancer Cell.
13:58–68. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmidt-Kittler O, Ragg T, Daskalakis A,
Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt
H, Muller P, et al: From latent disseminated cells to overt
metastasis: Genetic analysis of systemic breast cancer progression.
Proc Natl Acad Sci USA. 100:7737–7742. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
